Dialysis provider Fresenius Medical Care reported that net income in the third quarter of 2012 fell 3% to $270 million, or $0.88 a share. The world's largest dialysis provider said on it now expected 2012 revenue and net profit to be as much as 2% below its original forecast of about $14 billion and $1.14 billion respectively.
Dialysis treatments and clinics
As of Sept. 30, Fresenius Medical Care treated 256,521 patients worldwide, which represents a 12% increase compared to the previous year's figure. Fresenius Medical Care North America provided dialysis treatments for 163,454 patients, an increase of 16%. Including 31 clinics managed by Fresenius Medical Care North America, the number of patients in North America was 165,754. The international segment provided dialysis treatment to 93,067 patients, an increase of 6% over the prior year's figure, according to Fresenius.
The dialysis company operated a total of 3,135 dialysis clinics worldwide, which represents a 9% increase compared to year before. The number of dialysis clinics is comprised of 2,056 clinics in North America (2,087 including managed clinics), and 1,079 international dialysis clinics, representing an increase of 12% and 4%, respectively, according to Fresenius
During the first nine months of 2012, Fresenius Medical Care delivered approximately 28.6 million dialysis treatments worldwide. This represents an increase of 12%, compared to last year. Fresenius Medical Care North America accounted for 18.1 million dialysis treatments, an increase of 12%. The international segment delivered 10.5 million dialysis treatments, an increase of 13%, according to Fresenius
Fresenius Medical Care had 85,368 employees (full-time equivalents) worldwide, compared to 79,159 employees at the end of 2011. This increase of more than 6,200 employees is due to overall growth in the company's business and acquisitions including Liberty Dialysis Holdings Inc., according to Fresenius.